Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

ACC Conference Reporter

ESC Congress 2016 | ROME — The beta-blocker nebivolol (Bystolic) reduced early measures of cardiotoxicity from anthracycline chemotherapy for breast cancer, a small trial showed. Read More >>>

Keywords: ESC Congress


< Back to Listings